T80.411A Rh incompatibility with delayed hemolytic transfusion reaction, initial encounter

Name of the Condition

• Rh incompatibility with delayed hemolytic transfusion reaction, initial encounter.

Summary

This condition describes an immune-mediated hemolytic reaction occurring when Rh-negative individuals receive Rh-positive blood or blood products, leading to delayed destruction of red blood cells (hemolysis). It results from the recipient’s immune system recognizing Rh antigens as foreign, triggering antibody production and subsequent hemolysis. The reaction is classified as "delayed" because symptoms typically appear days to weeks after transfusion, and "initial encounter" indicates the reaction is newly diagnosed and being managed for the first time.

Causes

The reaction is triggered by the presence of Rh-positive red blood cells in an Rh-negative recipient, which the immune system identifies as foreign. This initiates antibody production, causing hemolysis. Transfusions of whole blood, packed red blood cells, or plasma products containing Rh-positive cells are common sources. The delayed nature suggests a pre-existing or newly formed antibody response that becomes active after transfusion.

Risk Factors

• Rh-negative blood type
• Prior exposure to Rh-positive blood (e.g., previous transfusions or pregnancy)
• Inadequate crossmatching or typing before transfusion
• Use of blood products with unknown Rh status

Symptoms

• Fever, chills, or rigors
• Jaundice or dark urine (hemoglobinuria)
• Anemia-related fatigue or pallor
• Shortness of breath or tachycardia
• Abdominal or back pain
• Elevated bilirubin levels (laboratory finding)

Diagnosis

Diagnosis involves confirming Rh incompatibility through blood typing and crossmatching, along with clinical assessment of transfusion history. Laboratory tests may show evidence of hemolysis, such as elevated bilirubin, decreased haptoglobin, and reticulocytosis. The timing of symptoms (days to weeks post-transfusion) helps distinguish this from acute reactions.

Treatment Options

Treatment focuses on managing hemolysis and its complications. This may include supportive care (e.g., hydration, monitoring for kidney function), discontinuing the transfusion, and addressing anemia if severe. In some cases, immunosuppressive therapy or plasmapheresis may be considered, depending on the extent of the reaction.

Prognosis and Follow-Up

Most patients recover with appropriate treatment, but outcomes depend on the severity of hemolysis and any associated complications (e.g., kidney injury). Follow-up typically includes monitoring for resolution of symptoms, repeat blood counts, and bilirubin levels. Long-term management may involve avoiding future Rh-positive transfusions.

Complications

• Acute kidney injury (due to hemoglobin release)
• Severe anemia requiring transfusion
• Disseminated intravascular coagulation (rare)
• Transfusion-related acute lung injury (TRALI, if concurrent)

Lifestyle & Prevention

Prevention relies on accurate blood typing and crossmatching before transfusion. Rh-negative individuals should avoid exposure to Rh-positive blood products unless necessary. For patients with a history of Rh incompatibility, future transfusions should use Rh-negative blood or washed products to minimize risk.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as fever, jaundice, dark urine, or severe fatigue occur after a transfusion, especially if they develop days to weeks later. Prompt evaluation is critical to manage hemolysis and prevent complications.

Tips for Medical Coders

Document the timing of the reaction (delayed, occurring days to weeks post-transfusion) and confirm it is the initial encounter. Include details of the transfusion history, blood type incompatibility, and clinical findings supporting hemolysis. Ensure the code T80.411A is used only for the initial encounter of a delayed hemolytic reaction due to Rh incompatibility.